James W Green Harvard Bioscience Inc (HBIO) insider trading activity

James W Green is Chief Executive Officer of HARVARD BIOSCIENCE INC. Currently has a direct ownership of 3.11 Million shares of HBIO, which is worth approximately $6.56 Million. The most recent transaction as insider was on Jun 13, 2024, when has been sold 10,000 shares (Common Stock) at a price of $2.91 per share, resulting in proceeds of $29,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.11M

0% 3M change

8.68% 12M change

Total Value Held $6.56 Million

James W Green Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 13 2024	BUY Open market or private purchase	$29,100 $2.91 p/Share	10,000 Added 0.32%	3,111,091 Common Stock
Jun 06 2024	BUY Open market or private purchase	$61,400 $3.07 p/Share	20,000 Added 0.64%	3,101,091 Common Stock
Mar 05 2024	BUY Grant, award, or other acquisition	-	429,594 Added 12.24%	3,081,091 Common Stock
Dec 31 2023	SELL Payment of exercise price or tax liability	$442,926 $5.35 p/Share	82,790 Reduced 3.03%	2,651,497 Common Stock
Dec 29 2023	SELL Payment of exercise price or tax liability	$686,897 $5.35 p/Share	128,392 Reduced 4.49%	2,734,287 Common Stock
Aug 17 2023	BUY Open market or private purchase	$109,500 $4.38 p/Share	25,000 Added 0.87%	2,862,679 Common Stock
Jun 11 2023	SELL Payment of exercise price or tax liability	$264,116 $5.46 p/Share	48,373 Reduced 1.68%	2,837,679 Common Stock
Mar 15 2023	BUY Open market or private purchase	$52,000 $2.6 p/Share	20,000 Added 0.69%	2,886,052 Common Stock
Mar 14 2023	BUY Open market or private purchase	$53,400 $2.67 p/Share	20,000 Added 0.69%	2,866,052 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	692,750 Added 19.58%	2,846,052 Common Stock
Jan 01 2023	SELL Payment of exercise price or tax liability	$136,621 $2.77 p/Share	49,322 Reduced 2.24%	2,153,302 Common Stock
Dec 29 2022	SELL Payment of exercise price or tax liability	$194,276 $2.55 p/Share	76,187 Reduced 3.34%	2,202,624 Common Stock
Dec 01 2022	BUY Open market or private purchase	$39,150 $2.61 p/Share	15,000 Added 0.65%	2,278,811 Common Stock
Nov 30 2022	BUY Open market or private purchase	$36,150 $2.41 p/Share	15,000 Added 0.66%	2,263,811 Common Stock
Aug 17 2022	BUY Open market or private purchase	$127,600 $3.19 p/Share	40,000 Added 1.75%	2,248,811 Common Stock
Jul 08 2022	SELL Payment of exercise price or tax liability	$361,807 $3.9 p/Share	92,771 Reduced 4.03%	2,208,811 Common Stock
Jun 15 2022	BUY Open market or private purchase	$111,300 $3.71 p/Share	30,000 Added 1.29%	2,301,582 Common Stock
Jun 11 2022	SELL Payment of exercise price or tax liability	$191,073 $3.95 p/Share	48,373 Reduced 2.09%	2,271,582 Common Stock
May 09 2022	BUY Open market or private purchase	$34,000 $3.4 p/Share	10,000 Added 0.43%	2,319,955 Common Stock
May 06 2022	BUY Open market or private purchase	$113,400 $3.78 p/Share	30,000 Added 1.28%	2,309,955 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	302,402 Added 11.71%	2,279,955 Common Stock
Jan 01 2022	SELL Payment of exercise price or tax liability	$334,339 $7.05 p/Share	47,424 Reduced 2.34%	1,977,554 Common Stock
Dec 29 2021	SELL Sale (or disposition) back to the issuer	$385,092 $7.27 p/Share	52,970 Reduced 2.55%	2,024,978 Common Stock
Nov 12 2021	SELL Bona fide gift	-	13,777 Reduced 0.66%	2,077,948 Common Stock
Aug 23 2021	SELL Open market or private sale	$386,364 $8.02 p/Share	48,175 Reduced 2.25%	2,091,725 Common Stock

JWG

James W Green

Chief Executive Officer

Holliston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HBIO shares.

Notify only if

Value

Insider Trading

Get notified when an Harvard Bioscience Inc insider buys or sells HBIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to HARVARD BIOSCIENCE INC

Track Activities on HBIO

Account